scholarly journals Does inflammation mediate the effect of pessimism on coronary heart disease? A ten-year follow-up study

2020 ◽  
Author(s):  
Mikko Pänkäläinen ◽  
Tuomas Kerola ◽  
Olli Kampman ◽  
Markku Kauppi ◽  
Hannu Sarkkinen ◽  
...  

Abstract BackgroundCoronary heart disease (CHD) is a notable cause of mortality worldwide. Psychosocial factors have been confirmed to have an effect on the risk for cardiovascular diseases and gradually pessimism has also been recognized as a risk factor for CHD. The mechanism by which pessimism elevates the risk for CHD is unknown. According to one theory pessimism increases low-level inflammation and an elevated inflammation level has in turn been connected with an increased risk for CHD. However, the theory of inflammation working as a mediator between pessimism and the onset of CHD has yet to be proven.MethodsWe conducted a ten-year prospective cohort study on a regional sample of three cohorts aged 52–56, 62–66, and 72–76 years at baseline (N=2,815). A revised version of the Life Orientation Test was used at baseline to define the levels of dispositional optimism and pessimism. The level of inflammation was determined by measuring the level of C-reactive protein using high sensitivity assays. These results and the data of new cases of CHD during the follow-up were used in the statistical analyses. The mediation effect of C-reactive protein between pessimism and new cases of CHD was calculated.ResultsStudy subjects with a new case of CHD during the follow-up were more pessimistic and had higher C-reactive protein values at baseline than other study subjects. The pessimism score and C-reactive protein value correlated statistically significantly. We found that the connection between pessimism and developing CHD during the study period was partially mediated via the level of C-reactive protein.ConclusionPessimism seemed to be a substantial risk factor for developing CHD. Pessimism was connected with the level of inflammation. The theory that elevated inflammation level mediates indirectly the connection between pessimism and the risk for CHD could be proved partially. Consequently, other mediators between pessimism and CHD remain unclear.

2011 ◽  
Vol 26 (S2) ◽  
pp. 611-611
Author(s):  
A. Bruschi ◽  
M. Mazza ◽  
D. Harnic ◽  
P. Grandinetti ◽  
C. Battaglia ◽  
...  

IntroductionThe aim of this preliminary study is to assess, in a sample of patients with Coronary Heart Disease (CHD), the specific association between depressive symptoms and systemic inflammation.MethodsSixty-One inpatients with CHD, 31 Unstable Angina and 28 Myocardial Infarction, participated in the study. The plasma levels of C Reactive Protein were measured using Dade Behring’s High Sensitivity CRP assay (hs-CRP) at T0, T30 and T90.At the same timings, they were tested by an examiner, unaware of their diagnosis, with a psychometric battery (SCL90-R, HDRS, MADRS, BDI, QlesQ).ResultsThe elevation of hs-CRP occurs during the whole observation period, with maximum significance at T90 (p = 0,031).A multivariate analysis at T0 indicates a statistical correlation between SCL90-R scores and hs-CRP levels (p = 0.02).The SCL90-R is also associated with the risk of further cardiac events (p = 0.013).Also the BDI could be useful as a prognostic factor (p = 0.026).We found a trend towards correlation between CRP values and depressive symptoms, but it never reaches statistical significance for the other scales.ConclusionsThe feelings of loss and the fear of death, related to the environmental and emotional situation of the hospitalization, may prevail in the acute phase of CHDs.Some patients may overcome this reactive depression, while others may exhibit a biological depression, related to the high level of CRP and thus to an increased risk of re-infarction and other coronary events.


Author(s):  
OJS Admin

Recently, the inammatory marker, high sensitivity C-reactive protein (hsCRP) has attracted clinical attention as a novel risk factor for Coronary Heart Disease (CHD) due to the immerging relationship between  inflammation and atheroma.


2021 ◽  
Author(s):  
Ling Liu ◽  
Qiu-Zhen Lin ◽  
Xue-Yan Zang ◽  
Yan Fu ◽  
Xingyu Wen ◽  
...  

Abstract High-sensitivity C-reactive protein (hs-CRP) is a key inflammatory factor in atherosclerotic cardiovascular diseases. In Chinese patients with coronary heart disease (CHD), the changes in hs-CRP levels after a daily meal and the effect of statins on those were never explored. A total of 300 inpatients with CHD were included. Hs-CRP levels were measured in fasting and non-fasting state at 2 hour (h) and 4h after a daily breakfast. Group with fasting hs-CRP ≤ 3mg/L had significantly higher percentage of patients with statins using ≥ 1 month (m) than that with fasting hs-CRP > 3mg/L (51.4% vs. 23.9%, P < 0.05). Hs-CRP levels were significantly higher in non-fasting state (P < 0.05). Interestingly, the hs-CRP didn’t elevate significantly in inpatients with statins using ≥ 1m in hs-CRP > 3mg/L group, but it elevated significantly after meal in inpatients without and with statins using < 1m (P < 0.05). About 32% of patients with non-fasting hs-CRP > 3mg/L came from those with fasting hs-CRP ≤ 3mg/L. In conclusion, hs-CRP levels increased significantly in CHD patients after a daily meal. When fasting hs-CRP > 3mg/L but not ≤ 3mg/L, statins work partly in reducing hs-CRP elevation in non-fasting state.


2008 ◽  
Vol 28 (7) ◽  
pp. 1385-1391 ◽  
Author(s):  
Hisatomi Arima ◽  
Michiaki Kubo ◽  
Koji Yonemoto ◽  
Yasufumi Doi ◽  
Toshiharu Ninomiya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document